Seizing Opportunities to Build Great ADCs by Thoughtful Pairing of Target, Antibody, & Payload

Time: 11:00 am
day: Track A - Day 2


  • Overview of Seagen’s novel ADC pipeline
  • Creating best-in-class ADC opportunities through strategic pairing of target and ADC biology
  • Analysing preclinical data supporting recent ADC opportunities employing both the cytotoxic and immune activating mechanisms of the clinically validated vedotin payload